上海医药（股票代码：02607）于2026年6月1日披露截至2026年5月31日的股份变动月报表。公告显示，公司（全称：上海医药集团股份有限公司）在报告期内的法定注册股本维持人民币3,708,361,809元不变，包含H股普通股919,072,704股和未在香港联交所上市的A股普通股2,789,289,105股，各类股份数量与上月保持一致。
公告指出，2026年5月公司无新的股份发行、购回、注销或以库藏方式持股等情况，已发行股份数量与结构与上月相同，无任何新变动。公司亦未披露与股份期权或股权激励计划相关的新增授出、行使或失效的信息。
按照上述报告，上海医药的已发行股份总数未发生变化，公司确认遵守香港联交所《上市规则》及相关法律规定，月报由联席公司秘书钟涛提交。公司整体股本继续保持稳定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.